Has the risk for atypical femur fractures associated with bisphosphonates changed the way you prescribe this drug for patients with osteoporosis?
Yes, I perform a more thorough patient evaluation before recommending bisphosphonates for osteoporosis.
Yes, I limit bisphosphonates use to five years or less.
Yes, both A and B.
No, the evidence is not strong enough to indicate that the risk outweighs benefits.
Vote
View Results
See this poll on:
https://poll.fm/4887513/embed
Leave a Comment
Your Name
Please enter your name.
Email Address
Please enter your email address.
Your Website (optional)
Your Comment
Please enter a comment.
0
/4000 chars
Submit Comment
Leave a Comment